Incidence of Hospital-Acquired Hyponatremia and its Risk Factors in Hospitalized Children: A Longitudinal Study

Elham Bakhtiari1, Farhad Heydarian2, Adeleh Azarshab3

  • 1Clinical Research Development Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad,Iran.

Insights

Hospital-acquired hyponatremia affects 22.1% of pediatric patients, with female sex identified as a key risk factor. Infants under one year may also be at increased risk, necessitating further investigation.

Area of Science:

  • Pediatric Medicine
  • Clinical Chemistry
  • Epidemiology

Background:

  • Hospital-acquired hyponatremia is a significant concern in pediatric care.
  • It is linked to various adverse clinical outcomes in children.
  • Understanding its incidence and risk factors is crucial for prevention and management.

Purpose of the Study:

  • To determine the incidence of hospital-acquired hyponatremia in pediatric patients.
  • To identify independent risk factors associated with its development.
  • To inform clinical practice and future research directions.

Main Methods:

  • A longitudinal study was conducted from 2016 to 2020.
  • Included hospitalized children with normal initial serum sodium levels.
  • Data collected on demographics, clinical factors, and outcomes; patients with abnormal admission sodium were excluded.

Main Results:

  • The incidence of hospital-acquired hyponatremia was 22.1%.
  • Female sex was a significant independent risk factor (OR 3.83).
  • Children under one year showed borderline significance as a risk factor (OR 2.68, P = .057).

Conclusions:

  • Hospital-acquired hyponatremia occurred in 22.1% of the studied pediatric population.
  • Female sex is an independent risk factor for developing hyponatremia during hospitalization.
  • Younger children (under one year) may also be at elevated risk, warranting further research.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...